Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Lymphoid 2Gastrointestinal 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Radiation Injuries 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Base Sequence × Thoracic × Clear all
NCT05122806 2026-04-29

BIOEXALK

Groupe Francais De Pneumo-Cancerologie

Phase NA Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06311981 2025-06-13

Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients

Shanghai Proton and Heavy Ion Center

Phase 2 Recruiting
29 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡